165.60
-1.56(-0.93%)
Currency In USD
| Previous Close | 167.16 |
| Open | 164.34 |
| Day High | 167.58 |
| Day Low | 160.84 |
| 52-Week High | 212 |
| 52-Week Low | 92.52 |
| Volume | 490,686 |
| Average Volume | 538,095 |
| Market Cap | 5.34B |
| PE | -103.5 |
| EPS | -1.6 |
| Moving Average 50 Days | 175.72 |
| Moving Average 200 Days | 156.73 |
| Change | -1.56 |
If you invested $1000 in iRhythm Technologies, Inc. (IRTC) since IPO date, it would be worth $6,357.01 as of January 21, 2026 at a share price of $165.6. Whereas If you bought $1000 worth of iRhythm Technologies, Inc. (IRTC) shares 5 years ago, it would be worth $657.46 as of January 21, 2026 at a share price of $165.6.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
iRhythm Technologies, Inc. Shares Preliminary Fourth Quarter 2025 Highlights and Business Update at the 44th Annual J.P. Morgan Healthcare Conference
GlobeNewswire Inc.
Jan 12, 2026 12:30 PM GMT
SAN FRANCISCO, Jan. 12, 2026 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC) a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today announced preliminary fourth quar
iRhythm Technologies to Present at the 44th Annual J.P. Morgan Healthcare Conference
GlobeNewswire Inc.
Dec 29, 2025 9:30 PM GMT
SAN FRANCISCO, Dec. 29, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, announced today that the company will
New Data at the Asia Pacific Heart Rhythm Society (APHRS) 2025 Highlight the Performance of iRhythm’s Zio Long-Term Continuous Monitoring in an Asian Population
GlobeNewswire Inc.
Nov 21, 2025 1:10 PM GMT
iRhythm Technologies presented new data during the joint Asia Pacific Heart Rhythm Society (APHRS) and Japan Heart Rhythm Society (JHRS) scientific sessions.Large-scale analysis of more than 400,000 patients1 supports the consistency and generalizabi